Zonisamide
Zonisamide is a sulfonamide anticonvulsant approved for use as an adjunctive therapy in adults with partial-onset seizures, infantile spasm, mixed seizure types of Lennox–Gastaut syndrome, myoclonic, and generalized tonic clonic seizure.
| Catalog Number | 10-101-130 |
| Alternative Name(s) | AD-810, CI-912, PD-110843, 1,2-Benzisoxazole-3-methanesulfonamide, 3-(Sulfamoylmethyl)-1,2-benzisoxazole, Benzo[d]isoxazol-3-yl-methanesulfonamide |
| Research Area | Zonisamide has been used in the treatment in Epilepsy & Parkinson's disease & Tardive dyskinesia & Obesity & Migraines & Bipolar depression. |
| Molecular Formula | C8H8N2O3S |
| CAS# | 68291-97-4 |
| Purity | >98% |
| Inchi | InChI=1S/C8H8N2O3S/c9-14(11,12)5-7-6-3-1-2-4-8(6)13-10-7/h1-4H,5H2,(H2,9,11,12) |
| Inchi Key | UBQNRHZMVUUOMG-UHFFFAOYSA-N |
| Size | Inquiry |
| Supplier Page | https://www.creative-peptides.com/product/zonisamide-item-10-101-130-124.html |